Elevated free fatty acids impair glucose metabolism in women: Decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia

Pankaj Shah, Adrian Vella, Ananda Basu, Rita Basu, Aron Adkins, W. Frederick Schwenk, C. Michael Johnson, K Sreekumaran Nair, Michael Dennis Jensen, Robert A. Rizza

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at ∼8.3 mmol/l and insulin was increased to ∼300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 ± 2.6 vs. 65.0 ± 7.9 μmol · kg-1 · min-1). Whole-body glucose disappearance (37.0 ± 2.2 vs. 70.9 ± 8.7 μmol · kg-1 · min-1; P < 0.001) and leg glucose uptake (24.3 ± 4.2 vs. 59.6 ± 10.0 μmol · kg fat-free mass of the leg-1 · min-1; P < 0.02) were also lower, whereas splanchnic glucose production (8.2 ± 0.8 vs. 4.3 ± 0.7 μmol · kg-1 · min-1; P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole-body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.

Original languageEnglish (US)
Pages (from-to)38-42
Number of pages5
JournalDiabetes
Volume52
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Viscera
Hyperinsulinism
Nonesterified Fatty Acids
Hyperglycemia
Glucose
Muscles
Glycerol
Heparin
Leg
Insulin
Somatostatin
Catheters

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Elevated free fatty acids impair glucose metabolism in women : Decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. / Shah, Pankaj; Vella, Adrian; Basu, Ananda; Basu, Rita; Adkins, Aron; Frederick Schwenk, W.; Johnson, C. Michael; Nair, K Sreekumaran; Jensen, Michael Dennis; Rizza, Robert A.

In: Diabetes, Vol. 52, No. 1, 01.01.2003, p. 38-42.

Research output: Contribution to journalArticle

@article{89ff34ea30314e0daaff735e02074554,
title = "Elevated free fatty acids impair glucose metabolism in women: Decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia",
abstract = "The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at ∼8.3 mmol/l and insulin was increased to ∼300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 ± 2.6 vs. 65.0 ± 7.9 μmol · kg-1 · min-1). Whole-body glucose disappearance (37.0 ± 2.2 vs. 70.9 ± 8.7 μmol · kg-1 · min-1; P < 0.001) and leg glucose uptake (24.3 ± 4.2 vs. 59.6 ± 10.0 μmol · kg fat-free mass of the leg-1 · min-1; P < 0.02) were also lower, whereas splanchnic glucose production (8.2 ± 0.8 vs. 4.3 ± 0.7 μmol · kg-1 · min-1; P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole-body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.",
author = "Pankaj Shah and Adrian Vella and Ananda Basu and Rita Basu and Aron Adkins and {Frederick Schwenk}, W. and Johnson, {C. Michael} and Nair, {K Sreekumaran} and Jensen, {Michael Dennis} and Rizza, {Robert A.}",
year = "2003",
month = "1",
day = "1",
doi = "10.2337/diabetes.52.1.38",
language = "English (US)",
volume = "52",
pages = "38--42",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Elevated free fatty acids impair glucose metabolism in women

T2 - Decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia

AU - Shah, Pankaj

AU - Vella, Adrian

AU - Basu, Ananda

AU - Basu, Rita

AU - Adkins, Aron

AU - Frederick Schwenk, W.

AU - Johnson, C. Michael

AU - Nair, K Sreekumaran

AU - Jensen, Michael Dennis

AU - Rizza, Robert A.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at ∼8.3 mmol/l and insulin was increased to ∼300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 ± 2.6 vs. 65.0 ± 7.9 μmol · kg-1 · min-1). Whole-body glucose disappearance (37.0 ± 2.2 vs. 70.9 ± 8.7 μmol · kg-1 · min-1; P < 0.001) and leg glucose uptake (24.3 ± 4.2 vs. 59.6 ± 10.0 μmol · kg fat-free mass of the leg-1 · min-1; P < 0.02) were also lower, whereas splanchnic glucose production (8.2 ± 0.8 vs. 4.3 ± 0.7 μmol · kg-1 · min-1; P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole-body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.

AB - The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at ∼8.3 mmol/l and insulin was increased to ∼300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 ± 2.6 vs. 65.0 ± 7.9 μmol · kg-1 · min-1). Whole-body glucose disappearance (37.0 ± 2.2 vs. 70.9 ± 8.7 μmol · kg-1 · min-1; P < 0.001) and leg glucose uptake (24.3 ± 4.2 vs. 59.6 ± 10.0 μmol · kg fat-free mass of the leg-1 · min-1; P < 0.02) were also lower, whereas splanchnic glucose production (8.2 ± 0.8 vs. 4.3 ± 0.7 μmol · kg-1 · min-1; P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole-body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.

UR - http://www.scopus.com/inward/record.url?scp=0037223317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037223317&partnerID=8YFLogxK

U2 - 10.2337/diabetes.52.1.38

DO - 10.2337/diabetes.52.1.38

M3 - Article

C2 - 12502491

AN - SCOPUS:0037223317

VL - 52

SP - 38

EP - 42

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 1

ER -